The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
Open accessAbstract
A tumor-homing peptide, F3, selectively binds to endothelial cells in tumor blood vessels and to tumor cells. Here, we show that the cell surface molecule recognized by F3 is nucleolin. Nucleolin specifically bound to an F3 peptide affinity matrix from extracts of cultured breast carcinoma cells. Antibodies and cell surface biotin labeling revealed nucleolin at the surface of actively growing cells, and these cells bound and internalized fluorescein-conjugated F3 peptide, transporting it into the nucleus. In contrast, nucleolin was exclusively nuclear in serum-starved cells, and F3 did not bind to these cells. The binding and subsequent internalization of F3 were blocked by an antinucleolin antibody. Like the F3 peptide, intravenously injected antinucleolin antibodies selectively accumulated in tumor vessels and in angiogenic vessels of implanted “matrigel” plugs. These results show that cell surface nucleolin is a specific marker of angiogenic endothelial cells within the vasculature. It may be a useful target molecule for diagnostic tests and drug delivery applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Self-citationGenes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
Self-citationTat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225
Major nucleolar proteins shuttle between nucleus and cytoplasm
Borer, R. A., Lehner, C. F., Eppenberger, H. M., & Nigg, E. A. (1989) · Cell · doi:10.1016/0092-8674(89)90241-9 · Cited by 1,114
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · cited 1×
“Examples include endothelial cell growth factor receptors and integrins (Eliceiri and Cheresh, 1999; Ferrara and Alitalo, 1999; Hynes, 2002), matrix metalloproteases (Brooks et al.”
BackgroundAminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Self-citationTumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Structure and functions of nucleolin
Ginisty, H., Sicard, H., Roger, B., & Bouvet, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.6.761 · Cited by 774
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Self-citationEliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
A reevaluation of integrins as regulators of angiogenesis
Hynes, R. O. (2002) · Nature Medicine · doi:10.1038/nm0902-918 · Cited by 548
Animal cell mutants defective in glycosaminoglycan biosynthesis.
Esko, J. D., Stewart, T. E., & Taylor, W. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3197 · Cited by 513
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 498
Self-citationMolecular dissection of nucleolin's role in growth and cell proliferation: new insights
Srivastava, M., & Pollard, H. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1911 · Cited by 494
Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides
Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110017200 · Cited by 430
Porkka, K., Laakkonen, P., Hoffman, J. A., Bernasconi, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062189599 · Cited by 291
Self-citationThe Cell-Surface-Expressed Nucleolin Is Associated with the Actin Cytoskeleton
Hovanessian, A. G., Puvion-Dutilleul, F., Nisole, S., Svab, J., Perret, E., Deng, J.-S., & Krust, B. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5071 · Cited by 244
Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y., & Muramatsu, T. (1993) · PubMed · Cited by 236
Nilsson, F., Kosmehl, H., Zardi, L., & Neri, D. (2001) · PubMed · Cited by 235
Protein localization to the nucleolus: a search for targeting domains in nucleolin
Schmidt-Zachmann, M. S., & Nigg, E. A. (1993) · Journal of Cell Science · doi:10.1242/jcs.105.3.799 · Cited by 218
Joyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Self-citationSinclair, J. F., & O'Brien, A. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110230200 · Cited by 195
Roghani, M., & Moscatelli, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41648-1 · Cited by 194
Nuclear Targeting by the Growth Factor Midkine
Shibata, Y., Muramatsu, T., Hirai, M., Inui, T., Kimura, T., Saito, H., McCormick, L. M., Bu, G., & Kadomatsu, K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6788-6796.2002 · Cited by 148
The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor
Said, E. A., Krust, B., Nisole, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201194200 · Cited by 138
Cellular Adhesion Mediated by Factor J, a Complement Inhibitor
Larrucea, S., González-Rubio, C., Cambronero, R., Ballou, B. T., Bonay, P., López‐Granados, E., Bouvet, P., Fontán, G., Fresno, M., & López‐Trascasa, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31718 · Cited by 84
An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.
Ngo, C., Gee, M. F. W., Akhtar, N., Yu, D., Volpert, O. V., Auerbach, R., & Thomas‐Tikhonenko, A. (2000) · PubMed · Cited by 81
Internalization of anti-nucleolin antibody into viable HEp-2 cells
Deng, J., Ballou, B. T., & Hofmeister, J. K. (1996) · Molecular Biology Reports · doi:10.1007/bf00351168 · Cited by 73
Identification of nucleolin as a new L-selectin ligand
Harms, G., Kraft, R., Grelle, G., Bärbel, V. O. L. Z., Dernedde, J., & Tauber, R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600531 · Cited by 60
FGF-2 Dependent Angiogenesis is a Latent Phenotype in Basic Fibroblast Growth Factor Transgenic Mice
Fulgham, D. L., Widhalm, S.-R., Martin, S. L., & Coffin, J. D. (1999) · Endothelium · doi:10.3109/10623329909053409 · Cited by 41
Effect of Laminin on the Nuclear Localization of Nucleolin in Rat Intestinal Epithelial IEC-6 Cells
Yu, D., Schwartz, M. Z., & Petryshyn, R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8754 · Cited by 24
Cited by
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Attia, M. F., Anton, N., Wallyn, J., Omran, Z., & Vandamme, T. F. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13098 · Cited by 1,085
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Self-citation
Metadata
- Authors
- Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., & Ruoslahti, E.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2003-11-24
- Volume
- 163
- Issue
- 4
- Pages
- 871-878
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2130389715
- Cited by
- 497
- References
- 35
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.